UBDE July 31 /PRNewswire-FirstCall/ -- U.S. BioDefense, Inc. (OTC Bulletin Board: UBDE - News) today announces it has finalized and received the $200,000 in funding from Equity Solutions. These funds will be used for corporate development and for concluding the pending acquisition of Emergency Disaster Systems (EDS).
U.S. BioDefense will use the funds to attract key management to support the pending acquisition and identify other merger and acquisition candidates. "Once the acquisition is finalized, the funds are critical to assure the rapid growth of EDS which will provide solid revenues for a company which has been largely based on research and development until this point," said David Chin, CEO of U.S. BioDefense.
The funds will also help expand the ongoing development of U.S. BioDefense's niche search engine for the biotechnology and defense industries. "With the explosion of information on the Internet, it has become critical to assist people to filter and organize that information. The progress that we have made in developing our search engine has been substantial and we expect a beta version to be ready by the fourth quarter of this year," stated David Chin.
"Our firm, which specializes in micro-cap companies, feels very strongly that U.S. BioDefense has tremendous potential for accelerated growth at this point in the company's life cycle. We look forward to working closely with Mr. Chin to help capitalize on their pending projects and assist in maximizing the exposure for U.S. BioDefense and its subsidiaries," said Eddie Cruz, CEO of Equity Solutions.
About U.S. BioDefense, Inc.
U.S. BioDefense is a Department of Defense central contractor that researches, develops, and commercializes leading-edge Biotech and Homeland Security Technologies. U.S. BioDefense, Inc. is focused on transferring, researching, and commercializing groundbreaking technology from Universities, Research Labs, Fortune 500 Companies, and Government Agencies.
About Equity Solutions, Inc.
Equity Solutions, Inc. (http://www.EquityIRSolutions.com) is a strategic corporate consulting firm focusing on providing resources for generating tangible results for its clients. These services include creating greater shareholder awareness, going public, assistance with merger and acquisitions.
This press release includes certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based on the current expectations or beliefs of management of U.S. BioDefense, Inc., and are subject to uncertainty and changes in circumstances. Actual results may vary materially from those expressed or implied by the statements herein due to changes in economic, business, competitive, technological and/or regulatory factors, and other factors affecting the operation of the businesses of U.S. BioDefense, Inc. U.S. BioDefense, Inc. is under no obligation to, and expressly disclaims any such obligation to, update or alter the respective forward-looking statements, whether as a result of new information, future events, or otherwise.
Anyone else think this has good potential to rise?
Posts: 596 | From: Kansas City | Registered: Jul 2006
| IP: Logged |